methylphenidate HCl ERCT
ApprovedWithdrawn 0 watching 0 views this week🔥 Hot
84
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Attention Deficit Hyperactivity Disorder (ADHD)
Conditions
Attention Deficit Hyperactivity Disorder (ADHD)
Trial Timeline
Sep 25, 2018 → Dec 3, 2020
NCT ID
NCT03546400About methylphenidate HCl ERCT
methylphenidate HCl ERCT is a approved stage product being developed by Pfizer for Attention Deficit Hyperactivity Disorder (ADHD). The current trial status is withdrawn. This product is registered under clinical trial identifier NCT03546400. Target conditions include Attention Deficit Hyperactivity Disorder (ADHD).
Hype Score Breakdown
Clinical
30
Activity
20
Company
9
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03546400 | Approved | Withdrawn |
Competing Products
20 competing products in Attention Deficit Hyperactivity Disorder (ADHD)
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| atomoxetine | Eli Lilly | Approved | 85 |
| Atomoxetine + Placebo | Eli Lilly | Phase 2/3 | 65 |
| Atomoxetine | Eli Lilly | Approved | 85 |
| Atomoxetine Hydrochloride | Eli Lilly | Approved | 85 |
| Atomoxetine | Eli Lilly | Phase 3 | 77 |
| Atomoxetine | Eli Lilly | Approved | 85 |
| Atomoxetine hydrochloride + Placebo | Eli Lilly | Approved | 85 |
| CLONICEL (Clonidine HCl sustained release) | Shionogi | Phase 3 | 77 |
| Donepezil hydrochloride + Placebo | Eisai | Phase 3 | 77 |
| LY2216684 + Methylphenidate + Placebo (tablet) + Placebo (capsule) | Eli Lilly | Phase 2/3 | 65 |
| Atomoxetine + Placebo | Eli Lilly | Approved | 85 |
| Atomoxetine | Eli Lilly | Approved | 85 |
| Atomoxetine | Eli Lilly | Pre-clinical | 23 |
| Atomoxetine Hydrochloride | Eli Lilly | Approved | 85 |
| Atomoxetine hydrochloride | Eli Lilly | Phase 3 | 77 |
| Atomoxetine Hydrochloride + Placebo | Eli Lilly | Approved | 85 |
| atomoxetine | Eli Lilly | Phase 3 | 77 |
| atomoxetine 0.5 mg/kg/day + placebo + atomoxetine 1.2 mg/kg/day + atomoxetine 1.2-1.4 mg/kg/day | Eli Lilly | Phase 3 | 77 |
| Atomoxetine Hydrochloride | Eli Lilly | Approved | 85 |
| Atomoxetine Hydrochloride | Eli Lilly | Phase 3 | 77 |